SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-336293"
 

Search: onr:"swepub:oai:DiVA.org:uu-336293" > Breast cancer in yo...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Breast cancer in young women and prognosis : How important are proliferation markers?

Fredholm, Hanna (author)
Karolinska Institutet
Magnusson, Kristina, 1979- (author)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Institutionen för immunologi, genetik och patologi
Lindstrom, Linda S. (author)
Karolinska Institutet
show more...
Tobin, Nicholas P. (author)
Karolinska Institutet
Lindman, Henrik (author)
Uppsala universitet,Experimentell och klinisk onkologi
Bergh, Jonas (author)
Karolinska Institutet
Holmberg, Lars (author)
Uppsala universitet,Endokrinkirurgi,Regional Cancer Center, Uppsala University Hospital, Uppsala, Sweden
Ponten, Fredrik (author)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Klinisk och experimentell patologi
Frisell, Jan (author)
Karolinska Institutet
Fredriksson, Irma (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
Elsevier BV, 2017
2017
English.
In: European Journal of Cancer. - : Elsevier BV. - 0959-8049 .- 1879-0852. ; 84, s. 278-289
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Aim:Compared to middle-aged women, young women with breast cancer have a higher risk of systemic disease. We studied expression of proliferation markers in relation to age and subtype and their association with long-term prognosis.Methods:Distant disease-free survival (DDFS) was studied in 504 women aged <40 years and 383 women aged >= 40 years from a population-based cohort. Information on patient characteristics, treatment and follow-up was collected from medical records. Tissue microarrays were produced for analysis of oestrogen receptor, progesterone receptor (PR), Her2, Ki-67 and cyclins.Results: Young women with luminal tumours had significantly higher expression of Ki-67 and cyclins. Proliferation markers were prognostic only within this subtype. Ki-67 was a prognostic indicator only in young women with luminal PR+ tumours. The optimal cut-off for Ki-67 varied by age. High expression of cyclin E1 conferred a better DDFS in women aged <40 years with luminal PR- tumours (hazard ratio [HR] 0.47 [0.24-0.92]). Age < 40 years was an independent risk factor of DDFS exclusively in women with luminal B PR+ tumours (HR 2.35 [1.22-4.50]). Young women with luminal B PR- tumours expressing low cyclin E1 had a six-fold risk of distant disease compared with luminal A ( HR 6.21 [2.17-17.6]).Conclusions:The higher expression of proliferation markers in young women does not have a strong impact on prognosis. Ki-67 is only prognostic in the subgroup of young women with luminal PR tumours. The only cyclin adding prognostic value beyond subtype is cyclin E1. Age is an independent prognostic factor only in women with luminal B PR+ tumours.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

Breast cancer
Young
Age
Subtype
Luminal
Progesterone receptor
Ki-67
Cyclin
Prognosis
Population-based

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view